Qianwen Zhang

Qianwen Zhang

Auto-generated profile, based on publicly available information

Qianwen Zhang

Department of Endocrinology and Metabolism, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2022 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
BFBiyun Feng
Biyun Feng
GCGuoying Chang
Guoying Chang
QZQianwen Zhang
Qianwen Zhang
XLXin Li
Xin Li
YTYijun Tang
Yijun Tang
XWXiu-Min Wang
Xiu-Min Wang
Background: Mosaic variegated aneuploidy (MVA) syndrome is a rare, autosomal recessive genetic disease. Here, we report an ultra‐rare case of MVA syndrome associated with a CEP57 variant.Methods: We retrospectively analyzed the clinical data of a 9‐year‐old female patient and surveyed her family members. Whole‐exome sequencing and karyotype analysis were performed; suspected mutations were verified using Sanger sequencing.Results: The patient presented with intrauterine growth restriction, short stature, microcephaly, facial dysmorphism, brachydactyly, and small teeth, and she showed unsatisfactory response to GH replacement therapy. Laboratory tests revealed high insulin‐like growth factor‐1 levels. Karyotype analysis of the peripheral blood showed mosaic variegated aneuploidies. Whole‐exome and Sanger sequencing revealed a novel homozygous nonsense variant, NM_014679.4: c.312 T > G, in CEP57 that leads to translation termination (p.Tyr104*). The parents were heterozygous carriers of the identified variant.Conclusion: This study presents an ultra‐rare case of CEP57‐driven MVA syndrome, identifying a novel homozygous nonsense variant of CEP57 (p.Tyr104*). Our findings enrich the CEP57 mutational spectrum and emphasize the importance of genetic testing in patients with microcephaly and short stature. Furthermore, we conclude that growth hormone treatment is ineffective in such patients.

19 July 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
SGShiyang Gao
Shiyang Gao
QZQianwen Zhang
Qianwen Zhang
BFBiyun Feng
Biyun Feng
SGShili Gu
Shili Gu
ZLZhiying Li
Zhiying Li
XWXiu-Min Wang
Xiu-Min Wang
Background: Primary ciliary dyskinesia (PCD) is a type of ciliary dyskinesia that is usually caused by autosomal recessive inheritance and can manifest as recurrent respiratory infections, bronchiectasis, infertility, laterality defects, and chronic otolaryngological disease. Although ependymal cilia, which affect the flow of cerebrospinal fluid in the central nervous system, have much in common with respiratory cilia in terms of structure and function, hydrocephalus is rarely associated with PCD. Recently, variants of Forkhead box J1 (FOXJ1) have been found to cause PCD combined with hydrocephalus in a de novo, autosomal dominant inheritance pattern.Methods: We performed DNA extraction, whole‐exome sequencing (WES) analysis, and mutation analysis of FOXJ1 and analyzed the patient's clinical and genetic data.Results: The patient was a 4‐year‐old female exhibiting normal growth and development. At 3 years and 2 months of age, the patient experienced hand shaking and weakness in the lower limbs. Cardiac ultrasonography showed a right‐sided heart, and cranial magnetic resonance imaging showed obstructive hydrocephalus. The nasal nitric oxide level was 54 nL/min. WES indicated a de novo, heterozygous variant of FOXJ1, c.734–735 ins20. This variant was novel, not included in the Human Gene Mutation and Genome Aggregation Database, and likely pathogenic according to the American College of Medical Genetics and Genomics, causing earlier termination of amino acid translation. The patient underwent a neuroendoscopic third ventriculostomy after the diagnosis of obstructive hydrocephalus. Six months after the operation, the patient's motor deficits had improved.Conclusion: This is the first report of a de novo, autosomal dominant pattern of FOXJ1 causing PCD combined with hydrocephalus in China. The patient's clinical symptoms were similar to those previously reported. WES confirmed that a novel variant of FOXJ1 was the cause of the PCD combined with hydrocephalus, expanding the spectrum of the genotypes associated with this condition. Physicians should be aware of the correlation of hydrocephalus and PCD and test for FOXJ1 variants.

28 January 2025 in Pediatric Diabetes
Verified
Journal Article
Open access
YDYu Ding
Yu Ding
QZQianwen Zhang
Qianwen Zhang
SGShiyang Gao
Shiyang Gao
JLJuan Li
Juan Li
GCGuoying Chang
Guoying Chang
XWXiumin Wang
Xiumin Wang
Background: In this study, we analysed the clinical and genetic characteristics and follow‐up data of patients with maturity‐onset diabetes of the young (MODY). Methods: From January 2015 to December 2022, patients with persistent hyperglycaemia suspected of having monogenic diabetes or diabetes syndrome were recruited, and next‐generation sequencing (NGS) was performed at the Shanghai Children’s Medical Center. Patients’ clinical and laboratory findings were recorded preceding follow‐ups. Candidate variants were verified using Sanger sequencing. Variant pathogenicity was evaluated according to the American College of Medical Genetics and Genomics (ACMG) guidelines. Results: Genetic testing was performed in 175 children. MODY‐related pathogenic or likely pathogenic gene variants were identified in 30 patients from different families. Of these, 11 were diagnosed with GCK ‐MODY (36.7%), six with INS ‐MODY (20%), five with HNF1A ‐MODY (16.7%), five with ABCC8 ‐MODY (16.7%), two with HNF1B ‐MODY (6.7%) and one with HNF4A ‐MODY (3.3%). There was one shift variant and seven splice‐site variants, and the rest were missense variants. We discovered six novel variants. Of the 30 patients, 63.3% had a family history of diabetes, 13.3% had diabetic ketoacidosis (DKA), and 16.7% had positive diabetes‐associated autoantibodies. The diabetes phenotype of patients with the INS variant was similar to that of patients with type 1 diabetes. All patients, including those having positive autoantibodies, required long‐term insulin therapy during follow‐ups. Four patients with the ABCC8 variant were unable to switch to oral sulfonylurea therapy and continued insulin therapy. Conclusion: Genetic testing is helpful for the precise diagnosis and treatment of patients with MODY, including those with DKA history and positive diabetes autoantibody. GCK ‐MODY is the most common type of MODY, and patients with INS variant account for a relatively large proportion of MODY cases in our cohort.

Verified
Journal Article
Open access
PDF file
QZQianwen Zhang
Qianwen Zhang
YHYiguo Huang
Yiguo Huang
SGShiyang Gao
Shiyang Gao
YDYu Ding
Yu Ding
HZHao Zhang
Hao Zhang
XWXiumin Wang
Xiumin Wang
Obesity-related ciliopathies, as a group of ciliopathies including Alström Syndrome and Bardet–Biedl Syndrome, exhibit distinct genetic and phenotypic variability. The understanding of these diseases is highly significant for understanding the functions of primary cilia in the human body, particularly regarding the relationship between obesity and primary cilia. The diagnosis of these diseases primarily relies on clinical presentation and genetic testing. However, there is a significant lack of research on biomarkers to elucidate the variability in clinical manifestations, disease progression, prognosis, and treatment responses. Through an extensive literature review, the paper focuses on obesity-related ciliopathies, reviewing the advancements in the field and highlighting the potential roles of biomarkers in the clinical presentation, diagnosis, and prognosis of these diseases.

13 July 2026 in Genes
Verified
Journal Article
Open access
PDF file
YTYijun Tang
Yijun Tang
YCYao Chen
Yao Chen
QZQianwen Zhang
Qianwen Zhang
JTJie Tang
Jie Tang
YDYu Ding
Yu Ding
XWXiu-Min Wang
Xiu-Min Wang
Background: Despite advances in genetic testing, many 46,XY Disorders of sex development (DSD) cases remain unsolved after whole-exome sequencing (WES). This study intended to explore rare variants in patients with micropenis, cryptorchidism, or hypospadias using bioinformatics analysis to identify potential pathogenic contributors and pathways underlying 46,XY DSD. Methods: A total of 35 patients with specific phenotypes (micropenis/cryptorchidism/hypospadias) and negative whole-exome sequencing results were enrolled. Bioinformatics analysis methods (SKAT-O test and GO enrichment) were applied to identify the putative loss-of-function (pLoF) variation, including nonsense, frameshift, and canonical splice-site variants, and predicted deleterious missense variants (CADD Phred > 20). Literature was reviewed to explore the correlation of detected candidate genes/pathways and 46,XY disorder of sex development. Results: After variant quality filtering, we identified 307,638 pLoF variants and 127,857 predicted deleterious missense variants across all samples. In subgroup A (micropenis, n = 21), we identified 146,268 pLoF variants and 104,746 predicted deleterious missense variants. In subgroup B (cryptorchidism, n = 10), we identified 111,172 pLoF variants and 77,244 predicted deleterious missense variants. In subgroup C (hypospadias, n = 4), we identified 50,198 pLoF variants and 23,111 predicted deleterious missense variants. Using SKAT-O with an initial screening threshold of p < 0.005 (FDR q < 0.05), we obtained 67 candidate genes from the pLoF variant set and 59 candidate genes from the predicted deleterious missense variant set in subgroup A; 81 and 11 candidate genes, respectively, in subgroup B; and 17 and 0 candidate genes, respectively, in subgroup C. Conclusions: Assessment of rare variants helps further explore the genetic contributors to 46,XY disorder of sex development and provide potential candidate genes and associated pathways.

24 October 2026 in eClinicalMedicine
Verified
Journal Article
Open access
SMShyam C. Madathil
Shyam C. Madathil
QZQianwen Zhang
Qianwen Zhang
TGTarekegn Geberhiwot
Tarekegn Geberhiwot